Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes.

作者信息

Morrow David A, Rifai Nader, Sabatine Marc S, Ayanian Shake, Murphy Sabina A, de Lemos James A, Braunwald Eugene, Cannon Christopher P

机构信息

Department of Medicine and TIMI Study Group, Cardiovascular Division, Brigham & Women's Hospital, 75 Francis St., Boston, MA 02115, USA.

出版信息

Clin Chem. 2003 Aug;49(8):1396-8. doi: 10.1373/49.8.1396.

DOI:10.1373/49.8.1396

PMID:12881457

Abstract

摘要

相似文献

Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes.

Clin Chem. 2003 Aug;49(8):1396-8. doi: 10.1373/49.8.1396.

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.

Circulation. 2003 Feb 11;107(5):690-5. doi: 10.1161/01.cir.0000049742.68848.99.

The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.

Am J Med. 2000 Aug 15;109(3):224-37. doi: 10.1016/s0002-9343(00)00474-5.

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.

Int J Cardiol. 2004 Feb;93(2-3):113-20. doi: 10.1016/S0167-5273(03)00157-8.

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials.

Circulation. 2001 Jan 16;103(2):201-6. doi: 10.1161/01.cir.103.2.201.

Oral glycoprotein IIb/IIIa antagonists in coronary artery disease.

Curr Cardiol Rep. 2001 Jan;3(1):63-71. doi: 10.1007/s11886-001-0012-2.

Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.

Am Heart J. 2003 Apr;145(4):622-7. doi: 10.1067/mhj.2003.6.

[Risk stratification in acute coronary syndrome].

Herz. 2001 Apr;26 Suppl 1:24-9. doi: 10.1007/pl00014028.

[The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].

Ital Heart J Suppl. 2000 Feb;1(2):202-11.

Elevation in serum troponin I predicts the benefit of tirofiban.

J Thromb Thrombolysis. 2001 May;11(3):211-5. doi: 10.1023/a:1011956703031.

引用本文的文献

Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Int J Mol Sci. 2022 May 19;23(10):5680. doi: 10.3390/ijms23105680.

Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome.

Clin Res Cardiol. 2012 Oct;101(10):837-45. doi: 10.1007/s00392-012-0469-6. Epub 2012 May 25.

Troponins and high-sensitivity troponins as markers of necrosis in CAD and heart failure.

Herz. 2009 Dec;34(8):600-6. doi: 10.1007/s00059-009-3306-6.

The reporting of cardiac troponin.

Clin Biochem Rev. 2003 Nov;24(4):99-108.

Association of platelet-monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non-st elevation acute coronary syndromes.

Clin Cardiol. 2007 Jan;30(1):26-31. doi: 10.1002/clc.2.

The PRIMA study: presentation ischaemia-modified albumin in the emergency department.

Emerg Med J. 2006 Oct;23(10):764-8. doi: 10.1136/emj.2006.036269.

British Cardiac Society Working Group on the definition of myocardial infarction.

Heart. 2004 Jun;90(6):603-9. doi: 10.1136/hrt.2004.038679.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验